Back to all studies
❤️
Phase 2
Cardiology
in-person
Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders
Sponsored by Mayo Clinic
Compensation
$500–$2,500
Duration
3 months
Location
Minnesota
About this study
The researchers are testing a medication named ravulizumab for the treatment of severe preeclampsia and Hemolysis, Elevated Liver enzymes, Low Platelets (HELLP) syndrome.
Who can participate
- • Adults aged 18–50
- • Female only
- • Diagnosed with or experiencing preeclampsia
- • Able to attend in-person clinic visits
What's included
- • Compensation up to $2,500
- • All study-related medical care at no cost
- • Lab work, screenings, and physician consultations
- • Study medication or treatment provided
IRB-approved study. Free to apply. Your information is kept confidential.
Ready to Find a Paid Study?
Join over 100,000 people who have been matched with clinical studies. It's free, fast, and could change your life.